Board-certified radiation oncologist Ana Botero, MD, has joined Miami Cancer Institute, part of Baptist Health South Florida. Dr. Botero specializes in treating brain, head and neck, lung, gastrointestinal, breast, gynecological, prostate and thyroid cancers, as well as oligometastatic diseases.
“We are pleased to welcome Dr. Botero to Miami Cancer Institute,” said Minesh Mehta, MD, deputy director and chief of radiation oncology at Miami Cancer Institute. “Her extensive training in radiation oncology and passion for providing evidence-based, compassionate patient care will make her an excellent addition to our team.”
“Dr. Botero is a well-recognized international speaker in radiation oncology, lecturing and teaching on topics related to radiosurgery and combined radiation and immunotherapy treatments,” said Leonard Kalman, MD, executive deputy director and chief medical officer at Miami Cancer Institute.
Prior to joining Miami Cancer Institute, Dr. Botero served as attending physician in the radiation oncology department at Memorial Cancer Institute, part of Memorial Health System. She is a board member of the Broward American Lung Association and member of the American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, International Association for the Study of Lung Cancer, American Brachytherapy Society and American Thyroid Association. She is also a founder-member of the Ibero Latin American Radiosurgery Society.
After earning a medical degree from Instituto de Ciencias de la Salud in Medellin, Colombia, Dr. Botero completed her residency in radiation oncology at the Washington University Mallinckrodt Institute of Radiology at Barnes-Jewish Hospital in St. Louis, Mo., where she served as an assistant professor of radiation oncology. She is Board certified in general surgery and radiation oncology.
Dr. Botero will see patients at Miami Cancer Institute, 8900 North Kendall Drive, Miami, FL 33176. She is fluent in English and Spanish.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology program in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with 11 hospitals, more than 23,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.